KRISTIE LIN, M.D.
Ophthalmology Physician · POMONA, CA
Individual Active NPI 1184801557
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 544 | 24,793 | $2,355,760 | $1,379,462 | $1,075,040 |
| 2023 | 499 | 17,093 | $1,971,616 | $1,145,514 | $878,872 |
| 2022 | 461 | 6,306 | $1,584,715 | $826,754 | $631,868 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 18,600 | $34 | $27 |
| 92014 | Established patient complete exam of visual system | 980 | $147 | $104 |
| 92134 | Imaging of retina | 929 | $47 | $36 |
| 67028 | Injection of drug into eye | 607 | $141 | $112 |
| 92250 | Photography of the retina | 591 | $39 | $28 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 583 | $197 | $155 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 468 | $28 | $21 |
| 92012 | Established patient problem focused exam of visual system | 408 | $105 | $80 |
| J9035 | Injection, bevacizumab, 10 mg | 268 | $72 | $57 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 143 | $188 | $127 |
| J0178 | Injection, aflibercept, 1 mg | 114 | $829 | $661 |
| 76512 | 2d ultrasound scan of eye tissue and structures | 27 | $54 | $43 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 114433 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1467617159
- NPI 1558720516
- NPI 1356473136
- NPI 1629383740
- NPI 1225263312
- NPI 1033183413
- NPI 1730191800
- NPI 1912058728
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.